Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Prevalence of Sarcopenia in elder Patients with Heart Failure- an underdiagnosed comorbidity
Session:
Sessão de Posters 56 - Medicina Cardiovascular: a Pessoa e a Doença
Speaker:
Ana Rita Correia de Sousa
Congress:
CPC 2024
Topic:
P. Other
Theme:
37. Miscellanea
Subtheme:
32.2 Chronic Nursing Care
Session Type:
Cartazes
FP Number:
---
Authors:
Ana Rita Sousa; Crisálida Ferreira; Margarida Madeira; Sara Gonçalves
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Introduction: Sarcopenia (SP) is a complex and multifactorial syndrome associated with aging, changes in nutritional and physical activity patterns, related to the decline in cognitive function and quality of life, with socioeconomic impact. The prevalence of sarcopenia in heart failure (HF) is increased and frequently undervalued.</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Purpose: To evaluate the prevalence of SP in a population of patients (pts) over 65 years of age with HF.</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Methods: We performed a prospective single center study to determine SP prevalence in pts with HF admitted in an outpatient clinic. Probable SP was defined as the presence of a hand grip strength <27kg in men and <16kg in women. SARC-F questionnaire score and chair stand test were also evaluated. Informed consent was obtained in all pts. Basal characteristics were determined. The population was divided and compared according to the presence or absence of SP. NYHA class IV pts were excluded.</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Results: 161 people were evaluated between October and November of 2023</span></span></span><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">, 65% of whom were male, mean age of 77+-7 years; 83% in Class I/II of NYHA; 76% had “slight” dependence/independence (Barthel score between 76-100). Regarding BMI assessment, 48% were obese and 10% were underweight. SP was present in 58% of the pts; 56% had a SARC-F >= 4 and 64% had a chair rise test > 15s. SP was more prevalent in elder patients ( 45% 65-69 years; 47% 70-79 years, 76% >80 years, p=0,002) ) in pts with advanced NYHA class ( 29% NYHA I, 57% in NYHA II and 81% NYHA III, p=0,004) , with Chronic kidney disease (79 vs 52%, p= 0.002), in pts with pulmonary disease (71 vs 52%, p=0,023) and in pts with higher levels of dependence (severe dependence 75% vs moderadate dependence 90% vs slight dependence 50%, p<0,001).</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><span style="color:#000000">Discussion and Conclusion: Sarcopenia was present in more than 50% of the individuals evaluated. Sarcopenia can be considered one of the most important causes of low physical performance and reduced cardiorespiratory fitness in elderly patients with HF, so early diagnosis and implementation of strategies to treat this condition in these patients is crucial to reduce the impact on the quality of life, morbidity and mortality of HF patients. The impact of SP in this population in adverse clinical events will be evaluated in the future and a rehabilitation plan regarding nutricional and exercice intervention is being developed.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site